HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

INNOGEN-B

4.080

-0.130-3.09%

Volume:9.61M

Turnover:39.19M

Market Cap:1.86B

PE:-4.43

High:4.230

Open:4.215

Low:4.010

Close:4.210

52wk High:53.000

52wk Low:4.010

Shares:457.00M

HK Float Shares:420.29M

Volume Ratio:0.70

T/O Rate:2.29%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-0.922

ROE:-36.91%

ROA:-17.30%

PB:1.52

PE(LYR):-4.43

PS:12.15

Loading ...

Overview Company News Filings

INNOGEN-B: Cowin Capital Investment Limited Disposes of Shares, Long Position Falls to 5.95%

Hong Kong Stock Market Update | INNOGEN-B (02591) Drops Over 5% to Hit New Low as Shareholder Trims Stake Post Lock-up Expiry

Huang Li Reduces Stake in INNOGEN-B (02591) by 3.35 Million Shares at Approximately HK$5.03 Each

INNOGEN-B: Weihe Zheng Disposes of Shares, Long Position Falls to 9.67%

1.89 Billion Hong Kong Dollar Deposit Value for INNOGEN-B as Shareholders Transfer 26.56 Million Shares to Haitong International Securities

Guangzhou Innogen Pharmaceutical Schedules 25 Aug Board Meeting to Approve 1H 2026 Results and Consider Interim Dividend

Bulletin Express

Guangzhou Innogen Pharma Schedules Board Meeting on Interim Results, Dividend Review

INNOGEN-B Maintains Stable Share Capital Structure in July 2026; Confirms Public Float Compliance

Bulletin Express

Innogen Pharma's Efsubaglutide Manufacturing Sites Receive Brazil GMP Certification

MT Newswires Live

Hong Kong Stock Movers: INNOGEN-B Surges Over 18% in Early Trading After Two Suzhou Pegloticase Alpha Injection Contract Sites Achieve PIC/S GMP Certification

INNOGEN-B (02591) Secures PIC/S GMP Certificates for Two Supplier Sites of Its Key Drug Candidate

Guangzhou Innogen Pharmaceutical - Obtainment of Pic/S Gmp Certificates for Two Contract Manufacturing Sites for Efsubaglutide Alfa Injection

THOMSON REUTERS

Guangzhou Innogen Says Anvisa Grants PIC/S GMP Certificates for Two Contract Sites for Ecnoglutide Alpha Injection

INNOGEN-B (02591) Depositary Shares Valued at HK$188 Million; Shareholder Deposits 25.29 Million Shares with Citibank

Innogen Pharma Doses First Patient in Phase 1b Trial of Obesity Drug

MT Newswires Live

INNOGEN-B completes first patient dosing in Phase Ib adolescent-obesity trial for Efsubaglutide Alfa

Bulletin Express

Guangzhou Innogen Pharmaceutical Group Co., Ltd (HKG:2591): Is Breakeven Near?

Simply Wall St.

Assessing Supply Chain Compliance Risks for a Company with a Single Commercial Product: The INNOGEN-B Patent Infringement Case

INNOGEN-B Shares Surge Over 17% Following NMPA Approval for Adolescent Weight Loss Trial of Esupaglutide α

Innogen Pharmaceutical CEO addresses DIA Global Annual Meeting 2026 China Town Hall

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/02591/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02591","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02591\",,,,,undefined,":{"symbol":"02591","market":"HK","secType":"STK","nameCN":"INNOGEN-B","latestPrice":4.08,"timestamp":1787299688008,"preClose":4.21,"halted":0,"volume":9608610,"delay":0,"changeRate":-0.03087885985748216,"floatShares":420285370,"shares":457000000,"eps":-0.9218411498561111,"marketStatus":"Market Closed","change":-0.13,"latestTime":"08-21 16:08:08","open":4.215,"high":4.23,"low":4.01,"amount":39193170,"amplitude":0.052257,"askPrice":4.08,"askSize":55400,"bidPrice":4.07,"bidSize":8200,"shortable":3,"etf":0,"ttmEps":-0.9650159885202579,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1787535000000},"marketStatusCode":7,"adr":0,"listingDate":1755187200000,"exchange":"SEHK","adjPreClose":4.21,"openAndCloseTimeList":[[1787275800000,1787284800000],[1787288400000,1787299200000]],"volumeRatio":0.7016963557043266,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02591\",,,,,undefined,":{"symbol":"02591","floatShares":420285370,"roa":"-17.30%","roe":"-36.91%","lyrEps":-0.921841,"volumeRatio":0.7016963557043266,"shares":457000000,"dividePrice":0,"high":4.23,"amplitude":0.052257,"preClose":4.21,"low":4.01,"week52Low":4.01,"pbRate":"1.52","psRate":"12.15","week52High":53,"institutionHeld":0,"latestPrice":4.08,"committee":-0.742138,"eps":-0.9218411498561111,"divideRate":0,"volume":9608610,"delay":0,"ttmEps":-0.9650159885202579,"open":4.215,"prevYearClose":30.64,"prevWeekClose":6.61,"prevMonthClose":7.26,"prevQuarterClose":7.09,"fiveDayClose":6.61,"twentyDayClose":7.59,"sixtyDayClose":11.84,"earningDate":1787587200000},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02591\",params:#limit:5,,,undefined,":[{"date":"2026-08-25","symbol":"02591","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787621400000,"name":null,"time":"","dateTimestamp":1787587200000,"actualEps":null},{"market":"HK","date":"2026-03-23","symbol":"02591","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1774195200000,"reportTimeType":"post","actualEps":null},{"date":"2025-08-29","symbol":"02591","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756431000000,"name":null,"time":"","dateTimestamp":1756396800000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02591\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02591\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":2,"updateTime":1775750400000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02591\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02591","date":"2026-08-21","current":-4.227909,"percent":1,"low":-137.156472,"twenty":-69.656366,"median":-50.052949,"eighty":-12.083492,"high":-5.675745,"avg":-45.707081,"sd":29.956855,"marketCap":1863822943},"quantilePoints":[{"date":"2025-08-15","current":-137.156472,"twenty":-137.156472,"median":-137.156472,"eighty":-137.156472,"marketCap":26152907730},{"date":"2025-08-22","current":-127.373977,"twenty":-129.344203,"median":-127.373977,"eighty":-126.417438,"marketCap":24211425497},{"date":"2025-08-29","current":-106.390102,"twenty":-127.373977,"median":-126.095992,"eighty":-114.007182,"marketCap":20319324643},{"date":"2025-09-05","current":-78.151342,"twenty":-127.373977,"median":-117.586994,"eighty":-99.491273,"marketCap":18939730209},{"date":"2025-09-12","current":-83.843855,"twenty":-126.417438,"median":-105.433356,"eighty":-83.374192,"marketCap":20355870191},{"date":"2025-09-19","current":-79.271387,"twenty":-126.095992,"median":-93.890147,"eighty":-81.90749,"marketCap":19232094592},{"date":"2025-09-26","current":-78.986763,"twenty":-125.916102,"median":-85.498552,"eighty":-79.429082,"marketCap":19113321562},{"date":"2025-10-03","current":-76.5387,"twenty":-122.116665,"median":-83.843855,"eighty":-78.76383,"marketCap":18565138343},{"date":"2025-10-10","current":-69.068341,"twenty":-116.871032,"median":-83.374192,"eighty":-77.810518,"marketCap":16728724560},{"date":"2025-10-17","current":-67.838616,"twenty":-109.436934,"median":-79.738352,"eighty":-74.826182,"marketCap":16418087403},{"date":"2025-10-24","current":-59.813644,"twenty":-105.816054,"median":-79.429082,"eighty":-68.576451,"marketCap":14481173363},{"date":"2025-10-31","current":-57.61442,"twenty":-103.460611,"median":-78.986763,"eighty":-66.346017,"marketCap":13969535692},{"date":"2025-11-07","current":-56.556997,"twenty":-100.097405,"median":-78.243448,"eighty":-63.14919,"marketCap":13704580470},{"date":"2025-11-14","current":-61.96171,"twenty":-95.010372,"median":-77.299283,"eighty":-61.326336,"marketCap":15056765743},{"date":"2025-11-21","current":-54.467459,"twenty":-87.179427,"median":-75.823033,"eighty":-60.1184,"marketCap":13229488347},{"date":"2025-11-28","current":-82.342484,"twenty":-85.508442,"median":-76.5387,"eighty":-60.703449,"marketCap":20072642195},{"date":"2025-12-05","current":-82.313405,"twenty":-85.248884,"median":-75.823033,"eighty":-61.326336,"marketCap":20100051356},{"date":"2025-12-12","current":-63.824496,"twenty":-84.462171,"median":-74.404407,"eighty":-61.326336,"marketCap":15614085348},{"date":"2025-12-19","current":-62.072323,"twenty":-83.725798,"median":-74.049705,"eighty":-60.286674,"marketCap":15221220708},{"date":"2025-12-24","current":-59.762449,"twenty":-83.548712,"median":-73.276127,"eighty":-59.816947,"marketCap":14700446650},{"date":"2026-01-02","current":-56.27243,"twenty":-83.409096,"median":-71.366231,"eighty":-59.572219,"marketCap":13896444596},{"date":"2026-01-09","current":-57.1291,"twenty":-82.548826,"median":-69.803372,"eighty":-58.239982,"marketCap":14143127045},{"date":"2026-01-16","current":-56.980838,"twenty":-82.319221,"median":-67.499105,"eighty":-57.682607,"marketCap":14152263432},{"date":"2026-01-23","current":-58.213825,"twenty":-82.096799,"median":-66.291021,"eighty":-57.601428,"marketCap":14444627815},{"date":"2026-01-30","current":-54.613459,"twenty":-81.934522,"median":-64.906051,"eighty":-57.510573,"marketCap":13613216600},{"date":"2026-02-06","current":-49.064319,"twenty":-80.235292,"median":-63.834,"eighty":-57.242442,"marketCap":12261031327},{"date":"2026-02-13","current":-50.165477,"twenty":-79.691019,"median":-62.941647,"eighty":-57.039695,"marketCap":12608214032},{"date":"2026-02-20","current":-50.419859,"twenty":-79.623791,"median":-62.643943,"eighty":-56.891323,"marketCap":12653895967},{"date":"2026-02-27","current":-50.052949,"twenty":-79.470699,"median":-62.017016,"eighty":-56.651056,"marketCap":12699577902},{"date":"2026-03-06","current":-43.88908,"twenty":-79.397543,"median":-60.902753,"eighty":-56.29247,"marketCap":11045891858},{"date":"2026-03-13","current":-39.965904,"twenty":-79.214462,"median":-60.292057,"eighty":-54.71959,"marketCap":10104843999},{"date":"2026-03-20","current":-39.174717,"twenty":-78.964109,"median":-59.813644,"eighty":-50.865048,"marketCap":9867297938},{"date":"2026-03-27","current":-24.701097,"twenty":-78.775514,"median":-59.491697,"eighty":-50.290678,"marketCap":9547524394},{"date":"2026-04-02","current":-24.535908,"twenty":-78.383597,"median":-58.823921,"eighty":-50.052949,"marketCap":9529251620},{"date":"2026-04-10","current":-24.978414,"twenty":-78.348547,"median":-58.584467,"eighty":-49.631191,"marketCap":9775934068},{"date":"2026-04-17","current":-23.474521,"twenty":-78.227102,"median":-58.112982,"eighty":-48.421657,"marketCap":9191205301},{"date":"2026-04-24","current":-19.658213,"twenty":-78.155492,"median":-57.844151,"eighty":-44.116877,"marketCap":7697406030},{"date":"2026-04-30","current":-16.329046,"twenty":-77.825679,"median":-57.660489,"eighty":-41.074266,"marketCap":6395470886},{"date":"2026-05-08","current":-17.822364,"twenty":-77.322024,"median":-57.626503,"eighty":-40.478309,"marketCap":5778764764},{"date":"2026-05-15","current":-17.368107,"twenty":-77.157551,"median":-57.517602,"eighty":-40.012158,"marketCap":5646287153},{"date":"2026-05-22","current":-17.112125,"twenty":-76.782452,"median":-57.446424,"eighty":-25.37304,"marketCap":5550355090},{"date":"2026-05-29","current":-15.607197,"twenty":-76.252433,"median":-57.23775,"eighty":-24.916387,"marketCap":5079831160},{"date":"2026-06-05","current":-14.014909,"twenty":-75.020932,"median":-57.073515,"eighty":-24.414835,"marketCap":4568193490},{"date":"2026-06-12","current":-11.752443,"twenty":-74.621039,"median":-56.924891,"eighty":-23.900197,"marketCap":3828146144},{"date":"2026-06-18","current":-10.549084,"twenty":-74.404407,"median":-56.73827,"eighty":-23.474521,"marketCap":3444417891},{"date":"2026-06-26","current":-9.60263,"twenty":-74.160764,"median":-56.642046,"eighty":-20.865982,"marketCap":3120076153},{"date":"2026-07-03","current":-11.351574,"twenty":-74.088566,"median":-56.533624,"eighty":-19.581214,"marketCap":3691100339},{"date":"2026-07-10","current":-11.238926,"twenty":-74.037218,"median":-56.208644,"eighty":-19.055481,"marketCap":3649986598},{"date":"2026-07-17","current":-10.540302,"twenty":-73.42668,"median":-55.144116,"eighty":-17.753872,"marketCap":3435281504},{"date":"2026-07-24","current":-10.636027,"twenty":-71.947117,"median":-53.621015,"eighty":-17.028947,"marketCap":3467258858},{"date":"2026-07-31","current":-10.1543,"twenty":-71.465685,"median":-51.153424,"eighty":-16.590446,"marketCap":3316508473},{"date":"2026-08-07","current":-10.609247,"twenty":-70.999854,"median":-50.412223,"eighty":-15.817726,"marketCap":3471827052},{"date":"2026-08-14","current":-9.215586,"twenty":-70.625283,"median":-50.222782,"eighty":-14.020929,"marketCap":3019575896},{"date":"2026-08-21","current":-5.675745,"twenty":-69.656366,"median":-50.052949,"eighty":-12.083492,"marketCap":1863822943}],"updateTime":1787455974040},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02591\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1154105787","title":"INNOGEN-B: Cowin Capital Investment Limited Disposes of Shares, Long Position Falls to 5.95%","url":"https://stock-news.laohu8.com/highlight/detail?id=1154105787","media":"HK Disclosure","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1154105787?lang=en_us&edition=fundamental","pubTime":"2026-08-19 17:12","pubTimestamp":1787130765,"startTime":"0","endTime":"0","summary":"Cowin Capital Investment Limited sold 1.54 million shares of INNOGEN-B stock at an average of HKD 4.4543 per share on August 19, 2026, involving about HKD 6.86 million.Prior to the disposal, Cowin...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02591"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107721532","title":"Hong Kong Stock Market Update | INNOGEN-B (02591) Drops Over 5% to Hit New Low as Shareholder Trims Stake Post Lock-up Expiry","url":"https://stock-news.laohu8.com/highlight/detail?id=1107721532","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1107721532?lang=en_us&edition=fundamental","pubTime":"2026-08-19 13:44","pubTimestamp":1787118253,"startTime":"0","endTime":"0","summary":"Shares of INNOGEN-B (02591) tumbled more than 5% in intraday trading, reaching a low of HK$4.22 and setting another historical bottom. As of the latest update, the stock was down 4.57% at HK$4.28,...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4588","VXUS","KCAI","BK1161","02591"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1140389532","title":"Huang Li Reduces Stake in INNOGEN-B (02591) by 3.35 Million Shares at Approximately HK$5.03 Each","url":"https://stock-news.laohu8.com/highlight/detail?id=1140389532","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1140389532?lang=en_us&edition=fundamental","pubTime":"2026-08-18 19:00","pubTimestamp":1787050817,"startTime":"0","endTime":"0","summary":"Hong Kong Stock Exchange filings reveal that on August 17, Huang Li disposed of 3.35 million shares of INNOGEN-B (02591) at a price of HK$5.0273 per share, totaling approximately HK$16.8415...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02591","EWH","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1154752673","title":"INNOGEN-B: Weihe Zheng Disposes of Shares, Long Position Falls to 9.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=1154752673","media":"HK Disclosure","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1154752673?lang=en_us&edition=fundamental","pubTime":"2026-08-18 17:14","pubTimestamp":1787044458,"startTime":"0","endTime":"0","summary":"On August 17, 2026, Weihe Zheng sold 3.35 million shares of INNOGEN-B at an average of HKD 5.0273 per share, involving about HKD 16.84 million.Prior to the disposal, Weihe Zheng's long position in...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02591"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1104450862","title":"1.89 Billion Hong Kong Dollar Deposit Value for INNOGEN-B as Shareholders Transfer 26.56 Million Shares to Haitong International Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=1104450862","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1104450862?lang=en_us&edition=fundamental","pubTime":"2026-08-14 08:26","pubTimestamp":1786667173,"startTime":"0","endTime":"0","summary":"Hong Kong Exchanges and Clearing Limited data shows that on August 13, INNOGEN-B (02591) experienced a significant position change, with a total deposit market value of 1.89 billion Hong Kong...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02591","BK1161","161027"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146232852","title":"Guangzhou Innogen Pharmaceutical Schedules 25 Aug Board Meeting to Approve 1H 2026 Results and Consider Interim Dividend","url":"https://stock-news.laohu8.com/highlight/detail?id=1146232852","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1146232852?lang=en_us&edition=fundamental","pubTime":"2026-08-13 17:09","pubTimestamp":1786612181,"startTime":"0","endTime":"0","summary":"Guangzhou Innogen Pharmaceutical Group Co., Ltd. has convened a board meeting for 25 August 2026. Directors will review and approve the consolidated interim results for the six months ended 30 June...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02591"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659013249","title":"Guangzhou Innogen Pharma Schedules Board Meeting on Interim Results, Dividend Review","url":"https://stock-news.laohu8.com/highlight/detail?id=2659013249","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659013249?lang=en_us&edition=fundamental","pubTime":"2026-08-13 16:38","pubTimestamp":1786610290,"startTime":"0","endTime":"0","summary":"Guangzhou Innogen Pharma schedules board meeting on interim results, dividend reviewGuangzhou Innogen Pharmaceutical will hold a board meeting on Aug. 25, 2026 to review interim results for the six mo","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nNDL3JLWd8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02591","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1166745114","title":"INNOGEN-B Maintains Stable Share Capital Structure in July 2026; Confirms Public Float Compliance","url":"https://stock-news.laohu8.com/highlight/detail?id=1166745114","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1166745114?lang=en_us&edition=fundamental","pubTime":"2026-08-05 17:27","pubTimestamp":1785922074,"startTime":"0","endTime":"0","summary":"Guangzhou Innogen Pharmaceutical Group Co., Ltd. (INNOGEN-B) filed its Monthly Return for Equity Issuer for the month ended 31 July 2026, indicating no movements in authorised, issued or treasury...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02591"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656824855","title":"Innogen Pharma's Efsubaglutide Manufacturing Sites Receive Brazil GMP Certification","url":"https://stock-news.laohu8.com/highlight/detail?id=2656824855","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656824855?lang=en_us&edition=fundamental","pubTime":"2026-08-04 13:45","pubTimestamp":1785822301,"startTime":"0","endTime":"0","summary":"Guangzhou Innogen Pharmaceutical  said two contract manufacturing sites for its Efsubaglutide Alfa injection project received good manufacturing practice  certification from Brazil's health regulator, ANVISA.The certification confirms the sites comply with Pharmaceutical Inspection Co-operation Scheme GMP standards and is expected to support commercial production capacity as well as the drug's registration and commercialization in PIC/S member countries, according to a Monday Hong Kong bourse filing.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["EWZS","02591","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1171803840","title":"Hong Kong Stock Movers: INNOGEN-B Surges Over 18% in Early Trading After Two Suzhou Pegloticase Alpha Injection Contract Sites Achieve PIC/S GMP Certification","url":"https://stock-news.laohu8.com/highlight/detail?id=1171803840","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1171803840?lang=en_us&edition=fundamental","pubTime":"2026-08-04 09:44","pubTimestamp":1785807856,"startTime":"0","endTime":"0","summary":"INNOGEN-B (02591) saw its shares climb more than 18% in early trading, though they later pared gains to trade up 10.23% at HK$7.815, with turnover reaching HK$23.282 million.Driving the move, INNOGEN...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VXUS","BK4588","02591","KCAI","BK1161","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1178875407","title":"INNOGEN-B (02591) Secures PIC/S GMP Certificates for Two Supplier Sites of Its Key Drug Candidate","url":"https://stock-news.laohu8.com/highlight/detail?id=1178875407","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1178875407?lang=en_us&edition=fundamental","pubTime":"2026-08-03 19:53","pubTimestamp":1785757985,"startTime":"0","endTime":"0","summary":"INNOGEN-B (02591) announced that as of July 27, 2026, two contract manufacturing sites for its Efesogliptin alfa injection project, both owned and operated by independent third parties, have...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02591"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656375774","title":"Guangzhou Innogen Pharmaceutical - Obtainment of Pic/S Gmp Certificates for Two Contract Manufacturing Sites for Efsubaglutide Alfa Injection","url":"https://stock-news.laohu8.com/highlight/detail?id=2656375774","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656375774?lang=en_us&edition=fundamental","pubTime":"2026-08-03 19:44","pubTimestamp":1785757449,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nFWN44010R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02591","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656757753","title":"Guangzhou Innogen Says Anvisa Grants PIC/S GMP Certificates for Two Contract Sites for Ecnoglutide Alpha Injection","url":"https://stock-news.laohu8.com/highlight/detail?id=2656757753","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656757753?lang=en_us&edition=fundamental","pubTime":"2026-08-03 19:43","pubTimestamp":1785757420,"startTime":"0","endTime":"0","summary":"Guangzhou Innogen says ANVISA grants PIC/S GMP certificates for two contract sites for ecnoglutide alpha injectionGuangzhou Innogen said two third-party contract manufacturing sites for its ecnoglutid","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nNDL6hQ8mJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02591"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1119793972","title":"INNOGEN-B (02591) Depositary Shares Valued at HK$188 Million; Shareholder Deposits 25.29 Million Shares with Citibank","url":"https://stock-news.laohu8.com/highlight/detail?id=1119793972","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1119793972?lang=en_us&edition=fundamental","pubTime":"2026-07-31 08:26","pubTimestamp":1785457575,"startTime":"0","endTime":"0","summary":"Data from the Hong Kong Stock Exchange shows that on July 30, a significant position change occurred in INNOGEN-B (02591), with depositary shares valued at a total of HK$188 million, representing a...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0128525689.USD","LU1791807156.HKD","LU0648001328.SGD","LU1244550221.USD","LU2125154778.USD","BK1161","LU2236285917.USD","LU0980610538.SGD","BK4207","LU0106831901.USD","LU2417539215.USD","LU1162221912.USD","LU0314106906.USD","LU0477156953.USD","IYF","02591","BK4566","LU1506573853.SGD","LU0170899867.USD","C","IE00BSNM7G36.USD","BK4504","FTXO","LU2456880835.USD","LU1074936037.SGD","LU1201861249.SGD","LU0203345920.USD","LU0130517989.USD","LU2125154935.USD","LU2462157665.USD","LU0130102774.USD","LU0162691827.USD","LU0320765646.SGD","LU0052756011.USD","LU0203347892.USD","TFNS","LU0310800965.SGD","LU1244550577.SGD","BK4559","LU1366192091.USD","LU1668664300.SGD","LU1244550494.USD","LU1267930227.SGD","BK4585","BK4534","BK4588","LU0098860793.USD","LU0072461881.USD","LU2360032135.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655830996","title":"Innogen Pharma Doses First Patient in Phase 1b Trial of Obesity Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2655830996","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655830996?lang=en_us&edition=fundamental","pubTime":"2026-07-29 10:50","pubTimestamp":1785293403,"startTime":"0","endTime":"0","summary":"Guangzhou Innogen Pharmaceutical  has enrolled and dosed the first patient in the Phase 1b clinical trial of Efsubaglutide Alfa for the treatment of adolescent obesity, according to a Tuesday Hong Kong bourse filing.The company said that no safety concerns or adverse reactions were observed during the post-dosing observation period.Shares of the pharma company were up more than 2% in Wednesday morning trade.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1161","02591"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1168740565","title":"INNOGEN-B completes first patient dosing in Phase Ib adolescent-obesity trial for Efsubaglutide Alfa","url":"https://stock-news.laohu8.com/highlight/detail?id=1168740565","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1168740565?lang=en_us&edition=fundamental","pubTime":"2026-07-28 20:46","pubTimestamp":1785242819,"startTime":"0","endTime":"0","summary":"Guangzhou Innogen Pharmaceutical Group Co., Ltd. (“INNOGEN-B”) reported that the first adolescent patient has been enrolled and dosed in the Phase Ib clinical trial of Efsubaglutide Alfa for obesity...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02591"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651156964","title":"Guangzhou Innogen Pharmaceutical Group Co., Ltd (HKG:2591): Is Breakeven Near?","url":"https://stock-news.laohu8.com/highlight/detail?id=2651156964","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651156964?lang=en_us&edition=fundamental","pubTime":"2026-07-16 11:38","pubTimestamp":1784173082,"startTime":"0","endTime":"0","summary":"Guangzhou Innogen Pharmaceutical Group Co., Ltd ( HKG:2591 ) is possibly approaching a major achievement in its...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2591/guangzhou-innogen-pharmaceutical-group-shares/news/guangzhou-innogen-pharmaceutical-group-co-ltd-hkg2591-is-bre","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2591/guangzhou-innogen-pharmaceutical-group-shares/news/guangzhou-innogen-pharmaceutical-group-co-ltd-hkg2591-is-bre","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["02591","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1101364795","title":"Assessing Supply Chain Compliance Risks for a Company with a Single Commercial Product: The INNOGEN-B Patent Infringement Case","url":"https://stock-news.laohu8.com/highlight/detail?id=1101364795","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1101364795?lang=en_us&edition=fundamental","pubTime":"2026-07-10 14:21","pubTimestamp":1783664460,"startTime":"0","endTime":"0","summary":"The Beijing Intellectual Property Court has recently accepted a utility model patent infringement case filed by Suzhou Jiashu Biology against Shanghai Yinno Medicine and Beijing JD Pharmacy. While JD...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02591","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1123803607","title":"INNOGEN-B Shares Surge Over 17% Following NMPA Approval for Adolescent Weight Loss Trial of Esupaglutide α","url":"https://stock-news.laohu8.com/highlight/detail?id=1123803607","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1123803607?lang=en_us&edition=fundamental","pubTime":"2026-06-23 09:58","pubTimestamp":1782179905,"startTime":"0","endTime":"0","summary":"Shares of INNOGEN-B (02591) are currently trading sharply higher, with gains exceeding 17%. At the time of writing, the stock is up 14.03% to HK$8.94, with a trading turnover of HK$45.71 million.The...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK1161","02591","BK4585","VXUS","IND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645040877","title":"Innogen Pharmaceutical CEO addresses DIA Global Annual Meeting 2026 China Town Hall","url":"https://stock-news.laohu8.com/highlight/detail?id=2645040877","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645040877?lang=en_us&edition=fundamental","pubTime":"2026-06-22 16:40","pubTimestamp":1782117613,"startTime":"0","endTime":"0","summary":"Innogen joined the DIA Global Annual Meeting 2026 China Town Hall session in Philadelphia.CEO Qinghua Wang outlined efsubaglutide alfa’s China approval for type 2 diabetes, citing ongoing obesity Phase 2 in Australia, diabetes bridging study in Brazil.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260622:nNDL147jTz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02591","BK1161"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":2,"totalSize":92,"code":"91000000","status":"200"}]}}